Carvalho Da Fonseca et al. reported that CCL2 secreted by glioma cells promotes tumor growth and the migration of malignant cells [61], and the CCL2–CCR2 axis promotes tumor progression by recruiting suppressive myeloid-derived suppressor cells [62,63]. The gene discussed is CCR2; the disease is central nervous system cancer.